XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Class A Common Stock, Class B Common Stock and Class C Capital Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2023   233,354      
Beginning balance at Dec. 31, 2023 $ 4,526 $ 0 $ 6,301 $ (1,770) $ (5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Class C capital stock upon exercise of stock options (in shares)   2,517      
Issuance of Class C capital stock upon exercise of stock options 96   96    
Vesting of restricted stock units (in shares)   4,967      
Share-based compensation expense 385   385    
Settlement of capped call transactions (in shares)   (2,141)      
Settlement of 2024/2025 Notes (in shares)   1,935      
Settlement of 2024/2025 Notes 1   1    
Repurchases of Class A common stock and Class C capital stock (in shares)   (7,096)      
Repurchases of Class A common stock and Class C capital stock (301)   (301)    
Net income (loss) (60)     (60)  
Other comprehensive income 9       9
Ending balance (in shares) at Sep. 30, 2024   233,536      
Ending balance at Sep. 30, 2024 4,656 $ 0 6,482 (1,830) 4
Beginning balance (in shares) at Jun. 30, 2024   231,407      
Beginning balance at Jun. 30, 2024 4,501 $ 0 6,322 (1,810) (11)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Class C capital stock upon exercise of stock options (in shares)   893      
Issuance of Class C capital stock upon exercise of stock options 35   35    
Vesting of restricted stock units (in shares)   1,442      
Share-based compensation expense 124   124    
Settlement of capped call transactions (in shares)   (2,141)      
Settlement of 2024/2025 Notes (in shares)   1,935      
Settlement of 2024/2025 Notes 1   1    
Net income (loss) (20)     (20)  
Other comprehensive income 15       15
Ending balance (in shares) at Sep. 30, 2024   233,536      
Ending balance at Sep. 30, 2024 4,656 $ 0 6,482 (1,830) 4
Beginning balance (in shares) at Dec. 31, 2024   242,489      
Beginning balance at Dec. 31, 2024 $ 4,848 $ 0 6,733 (1,882) (3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Class C capital stock upon exercise of stock options (in shares) 4,193 4,193      
Issuance of Class C capital stock upon exercise of stock options $ 176   176    
Vesting of restricted stock units (in shares)   4,551      
Share-based compensation expense 343   343    
Settlement of capped call transactions (in shares)   (3,097)      
Settlement of capped call transactions 38   38    
Settlement of 2024/2025 Notes (in shares)   1      
Repurchases of Class A common stock and Class C capital stock (in shares)   (6,102)      
Repurchases of Class A common stock and Class C capital stock (438)   (438)    
Net income (loss) 20     20  
Other comprehensive income 5       5
Ending balance (in shares) at Sep. 30, 2025   242,035      
Ending balance at Sep. 30, 2025 4,992 $ 0 6,852 (1,862) 2
Beginning balance (in shares) at Jun. 30, 2025   241,132      
Beginning balance at Jun. 30, 2025 4,746 $ 0 6,617 (1,872) 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Class C capital stock upon exercise of stock options (in shares)   2,873      
Issuance of Class C capital stock upon exercise of stock options 121   121    
Vesting of restricted stock units (in shares)   1,584      
Share-based compensation expense 114   114    
Settlement of capped call transactions (in shares)   (3,097)      
Settlement of capped call transactions 38   38    
Repurchases of Class A common stock and Class C capital stock (in shares)   (457)      
Repurchases of Class A common stock and Class C capital stock (38)   (38)    
Net income (loss) 10     10  
Other comprehensive income 1       1
Ending balance (in shares) at Sep. 30, 2025   242,035      
Ending balance at Sep. 30, 2025 $ 4,992 $ 0 $ 6,852 $ (1,862) $ 2